Ziling Liu Selected Research

N-isopropylacrylamide

3/2022	Corrigendum to "N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells" [Colloids Surf. B Biointerfaces 198 (2021) 111463].
2/2021	N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziling Liu Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 08/2011
5	Lung Neoplasms (Lung Cancer) 03/2022 - 08/2011
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 05/2019
3	Brain Neoplasms (Brain Tumor) 01/2022 - 07/2021
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 05/2015
2	Disease Progression 01/2022 - 07/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2018
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Hand-Foot Syndrome 01/2021 - 01/2019
2	Leukemia 01/2021 - 08/2011
2	Inflammation (Inflammations) 01/2021 - 06/2016
2	Malaria 08/2020 - 02/2019
2	Asymptomatic Infections 08/2020 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2019
1	Ependymoma 01/2022
1	Fistula 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Renal Insufficiency (Renal Failure) 10/2020
1	Infections 08/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2019
1	Parasitic Diseases (Parasitic Disease) 02/2019
1	Necrosis 01/2019
1	Residual Neoplasm 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Colitis-Associated Neoplasms 06/2017

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
3	Pharmaceutical PreparationsIBA 10/2020 - 01/2019
2	N-isopropylacrylamideIBA 03/2022 - 02/2021
2	PolyethyleneimineIBA 03/2022 - 02/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2021
2	1-dodecylpyridoxal (PLD)IBA 01/2022 - 01/2021
2	liposomal doxorubicin (Doxil)FDA Link 01/2022 - 01/2021
2	dacomitinibIBA 12/2021 - 07/2021
2	MethyltransferasesIBA 01/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 07/2020
2	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 09/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 05/2019 - 02/2019
2	Arsenic Trioxide (Trisenox)FDA Link 10/2015 - 06/2004
1	Colloids (Colloid)IBA 03/2022
1	toripalimabIBA 01/2022
1	2-amino-6-chloropurineIBA 01/2022
1	Poly(amidoamine)IBA 01/2022
1	apatinibIBA 01/2022
1	alectinibIBA 01/2022
1	CytokinesIBA 01/2022
1	Nanoparticle Drug Delivery SystemIBA 01/2022
1	VimentinIBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	PlatinumIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	LigandsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2021
1	Tyrosine Kinase InhibitorsIBA 07/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021
1	Decitabine FDA Link 01/2021
1	C.I. direct red 80IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	CollagenIBA 01/2021
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Capsules (Microcapsules)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 08/2020
1	Codon (Codons)IBA 08/2020
1	Folic Acid AntagonistsIBA 08/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2020
1	EnzymesIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2019
1	Sirtuin 3IBA 09/2019
1	Adenosine Triphosphate (ATP)IBA 05/2019
1	Bile Pigments (Bilin)IBA 02/2019
1	Axitinib (AG 013736)IBA 01/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	fosbretabulin (combretastatin A4)IBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2018
1	KinesinsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2017
1	parecoxibIBA 06/2016

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2015
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2011
3	Immunotherapy 01/2022 - 05/2015
2	Radiotherapy 10/2020 - 04/2016
1	Intravenous Injections 01/2022
1	Operative Surgical Procedures 01/2021
1	Renal Dialysis (Hemodialysis) 10/2020
1	Combination Drug Therapy (Combination Chemotherapy) 07/2020
1	Lymph Node Excision (Lymph Node Dissection) 07/2020
1	Splenectomy 06/2016